trending Market Intelligence /marketintelligence/en/news-insights/trending/yauruo9fz0owjhmpsym-3a2 content esgSubNav
In This List

Biocure Technology director resigns; replacement named

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Biocure Technology director resigns; replacement named

Canada's Biocure Technology Inc. said Marco Nonni resigned as a director.

Nonni joined the company's board in April, and will continue working with Biocure Technology on a consulting basis.

The company appointed Hans Frykman to replace Nonni, effective Sept. 4.

Frykman is medical director at Neurocode Labs and UBC Diagnostic Services Lab.

Biocure Technology develops and commercializes biosimilar pharmaceutical products in South Korea.